Jennifer DiMauro - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Jennifer DiMauro

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Bioorganic & Medicinal Chemistry Letters|March 26, 2016

Creation of a S1P Lyase bacterial surrogate for structure-based drug designMaria A Argiriadi, David Banach, Elzbieta Radziejewska, et al.

BMC Structural Biology|March 20, 2009

Rational mutagenesis to support structure-based drug design: MAPKAP kinase 2 as a case studyMaria A Argiriadi, Silvino Sousa, David Banach, et al.

Bioorganic & Medicinal Chemistry Letters|November 19, 2009

2,4-Diaminopyrimidine MK2 inhibitors. Part I: Observation of an unexpected inhibitor binding modeMaria A Argiriadi, Anna M Ericsson, Christopher M Harris, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Bioorganic & Medicinal Chemistry Letters|March 26, 2016

Creation of a S1P Lyase bacterial surrogate for structure-based drug designMaria A Argiriadi, David Banach, Elzbieta Radziejewska, et al.

BMC Structural Biology|March 20, 2009

Rational mutagenesis to support structure-based drug design: MAPKAP kinase 2 as a case studyMaria A Argiriadi, Silvino Sousa, David Banach, et al.

Bioorganic & Medicinal Chemistry Letters|November 19, 2009

2,4-Diaminopyrimidine MK2 inhibitors. Part I: Observation of an unexpected inhibitor binding modeMaria A Argiriadi, Anna M Ericsson, Christopher M Harris, et al.

Pageof 2